XML 76 R57.htm IDEA: XBRL DOCUMENT
v3.20.4

REVENUE - Revenue by Geographic Segment (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended
--- | --- | ---
Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Sep. 30, 2019 | Jun. 30, 2019 | Mar. 31, 2019 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales | $ 749,329 | $ 759,153 | $ 699,305 | $ 721,553 | $ 671,333 | $ 701,278 | $ 742,661 | $ 744,460 | $ 2,929,340 | $ 2,859,732 | $ 2,764,761
Beauty + Home |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 1,298,151 | 1,352,714 | 1,426,382
Pharma |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 1,225,779 | 1,091,051 | 954,652
Food + Beverage |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 405,410 | 415,967 | 383,727
Europe |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 1,604,056 | 1,638,469 | 1,627,478
Europe | Beauty + Home |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 681,936 | 792,255 | 816,359
Europe | Pharma |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 808,834 | 729,882 | 696,079
Europe | Food + Beverage |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 113,286 | 116,332 | 115,040
Domestic |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 965,986 | 836,768 | 726,336
Domestic | Beauty + Home |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 384,004 | 310,411 | 334,881
Domestic | Pharma |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 350,265 | 297,871 | 196,928
Domestic | Food + Beverage |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 231,717 | 228,486 | 194,527
Latin America |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 194,043 | 220,388 | 235,619
Latin America | Beauty + Home |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 141,846 | 160,048 | 178,392
Latin America | Pharma |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 23,157 | 26,344 | 25,485
Latin America | Food + Beverage |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 29,040 | 33,996 | 31,742
Asia |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 165,255 | 164,107 | 175,328
Asia | Beauty + Home |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 90,365 | 90,000 | 96,750
Asia | Pharma |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | 43,523 | 36,954 | 36,160
Asia | Food + Beverage |  |  |  |  |  |  |  |  |  |  |
REVENUE |  |  |  |  |  |  |  |  |  |  |
Net Sales |  |  |  |  |  |  |  |  | $ 31,367 | $ 37,153 | $ 42,418

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=atr_BeautyAndHomeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=atr_PharmaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=atr_FoodBeverageMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_EuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_NorthAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_LatinAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_AsiaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |